Search - tctmd.com

Displaying 721 - 740 of 806

Sort: Relevancy | Date

Presentation TCT 2012

Dedicated Bifurcation Stents: Minvasys Nile Program Update

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Cappella Program Update

Presenter: Fernando Cura

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Biosensors Program Update

Presenter: Stefan Verheye

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

Bioabsorbable Stents

Presenter: Hector Garcia-Garcia

October 22, 2012

Presentation TCT 2012

Are the Outcomes of Left Main Stenting Improving with Second Generation Stents? Results of PRECOMBAT-2

Presenter: Young-Hak Kim

October 22, 2012

Presentation TCT 2012

When Are Two Stents Not Needed for the Distal Left Main Bifurcation?

Presenter: David Hildick-Smith

October 22, 2012

Presentation TCT 2012

The Data Are Clear: The Careful Operator Should Implant Two Stents in No More Than 10% of Bifurcation Lesions!

Presenter: Liliana Grinfeld

October 22, 2012

Presentation TCT 2012

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Presenter: Masato Nakamura

October 22, 2012

Presentation TCT 2012

Final Data on the ICARUS Trial of Covered Stents for Obstructive Iliac Disease

Presenter: John Laird Jr

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Xience SBA Program Update

Presenter: David Rizik

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: STENTYS Program Update

Presenter: Stefan Verheye

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Presenter: Lawrence Garcia

October 22, 2012

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Presenter: 17338|Subhash Banerjee

September 12, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

Presentation

Effect of Biolimus-Eluting Stents with Biodegradable Polymer vs. BMS on Cardiovascular Events in AMI

Presenter: L. R?ber

August 21, 2012

Presentation

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

August 21, 2012

Presentation

Long-term Outcome of Stents vs. CABG in Diabetic and Nondiabetic Patients with Multivessel or Left Main CAD

Presenter: D-W Park

August 14, 2012

Presentation

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Presenter: Takeshi Kimura

July 27, 2012

Advertisement

Dedicated Bifurcation Stents: Minvasys Nile Program Update

Dedicated Bifurcation Stents: Cappella Program Update

Dedicated Bifurcation Stents: Biosensors Program Update

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Bioabsorbable Stents

Are the Outcomes of Left Main Stenting Improving with Second Generation Stents? Results of PRECOMBAT-2

When Are Two Stents Not Needed for the Distal Left Main Bifurcation?

The Data Are Clear: The Careful Operator Should Implant Two Stents in No More Than 10% of Bifurcation Lesions!

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Final Data on the ICARUS Trial of Covered Stents for Obstructive Iliac Disease

Dedicated Bifurcation Stents: Xience SBA Program Update

Dedicated Bifurcation Stents: STENTYS Program Update

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Effect of Biolimus-Eluting Stents with Biodegradable Polymer vs. BMS on Cardiovascular Events in AMI

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Long-term Outcome of Stents vs. CABG in Diabetic and Nondiabetic Patients with Multivessel or Left Main CAD

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content